Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Aug;101(8):1875-1886.
doi: 10.1097/TP.0000000000001776.

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals

Affiliations
Multicenter Study

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals

Bénédicte Sautenet et al. Transplantation. 2017 Aug.

Abstract

Background: Inconsistencies in outcome reporting and frequent omission of patient-centered outcomes can diminish the value of trials in treatment decision making. We identified critically important outcome domains in kidney transplantation based on the shared priorities of patients/caregivers and health professionals.

Methods: In a 3-round Delphi survey, patients/caregivers and health professionals rated the importance of outcome domains for trials in kidney transplantation on a 9-point Likert scale and provided comments. During rounds 2 and 3, participants rerated the outcomes after reviewing their own score, the distribution of the respondents' scores, and comments. We calculated the median, mean, and proportion rating 7 to 9 (critically important), and analyzed comments thematically.

Results: One thousand eighteen participants (461 [45%] patients/caregivers and 557 [55%] health professionals) from 79 countries completed round 1, and 779 (77%) completed round 3. The top 8 outcomes that met the consensus criteria in round 3 (mean, ≥7.5; median, ≥8; proportion, >85%) in both groups were graft loss, graft function, chronic rejection, acute rejection, mortality, infection, cancer (excluding skin), and cardiovascular disease. Compared with health professionals, patients/caregivers gave higher priority to 6 outcomes (mean difference of 0.5 or more): skin cancer, surgical complications, cognition, blood pressure, depression, and ability to work. We identified 5 themes: capacity to control and inevitability, personal relevance, debilitating repercussions, gaining awareness of risks, and addressing knowledge gaps.

Conclusions: Graft complications and severe comorbidities were critically important for both stakeholder groups. These stakeholder-prioritized outcomes will inform the core outcome set to improve the consistency and relevance of trials in kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. Consensus criteria and outcome domains
Outcomes included in the potential core outcome set met at least two of the following criteria: mean score of greater than or equal to 7.5; mean score greater than or equal to 8; proportion of participants rating the outcome 7 to 9 (critically important) is greater than or equal to 75, and the median is less than 10 based on the forced ranking question.
Figure 2
Figure 2
Mean scores of patients/caregivers in rounds 1–3
Figure 3
Figure 3
Mean scores of health professionals in rounds 1–3
Figure 4
Figure 4. Differences in mean scores between patients/caregivers and health professionals in rounds 1–3
*The top 8 outcome domains for both stakeholder groups that met at least two of the following criteria: mean score of greater than or equal to 7.5; mean score greater than or equal to 8; proportion of participants rating the outcome 7 to 9 (critically important) is greater than or equal to 75, and the median is less than 10 based on the forced ranking question.

Comment in

References

    1. Stegall MD, Gaston RS, Cosio FG, Matas A. Through a glass darkly: seeking clarity in preventing late kidney transplant failure. J Am Soc Nephrol. 2015;26(1):20–9. - PMC - PubMed
    1. Shapiro R, Basu A, Tan H, et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg. 2005;200(4):505–A61. - PMC - PubMed
    1. Lodhi SA, Meier-Kriesche H-U. Kidney allograft survival: the long and short of it. Nephrol Dial Transplant. 2011;26(1):15–7. - PubMed
    1. Nankivell BJ, Kuypers DRJ. Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011;378(9800):1428–37. - PubMed
    1. Matas AJ, Gillingham KJ, Humar A, et al. 2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant. 2008;8(11):2410–9. - PMC - PubMed

Publication types